Literature DB >> 11074660

Modulation of steroidogenesis in human ovarian granulosa cells during aging.

R Denkova1, V Bourneva, K Baleva, E Yaneva, B Nikolov, I Christov, I Ivanov.   

Abstract

OBJECTIVE: To investigate the in vitro effect of endothelin-1 (ET-1) on the steroid production (progesterone [P] and estradiol [E2]) by cultured human granulosa cells (GCs) during aging.
MATERIAL AND METHODS: Human ovarian GCs and granulosa-luteal cells (GLCs) were isolated from ovaries of female patients (young and premenopausal) undergoing surgery for non-ovarian benign gynecological conditions. Cells were cultured with ET-1 in the presence or in the absence of FSH. The concentrations of P and E2 in conditioned media were determined by means of RIA.
RESULTS: In human GCs and GLCs obtained from young and premenopausal women, ET-1 in vitro can significantly reduce the FSH stimulated biosynthesis of P, whereas the basal P biosynthesis is only insignificantly diminished. The in vitro application of ET-1 have only a sparse inhibitory effect on both the basal and FSH stimulated biosynthesis of E2 in GCs from the two patient groups.
CONCLUSIONS: Our findings support the opinion that ET-1 is a local regulator of ovarian steroidogenesis which might modulate the steroid production and the stimulatory effect of FSH in cultured GCs and GLCs obtained from women at various ages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074660

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  2 in total

1.  Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-ovulatory follicle.

Authors:  Dong-Hee Choi; Eun Kyung Kim; Kyeoung-Hwa Kim; Kyung-Ah Lee; Dong-Wook Kang; Hey Young Kim; Phillip Bridges; Chemyong Ko
Journal:  Hum Reprod       Date:  2011-03-15       Impact factor: 6.918

Review 2.  Endothelin 2: a key player in ovulation and fertility.

Authors:  CheMyong J Ko; Yoon Min Cho; Eugene Ham; Joseph A Cacioppo; Chan Jin Park
Journal:  Reproduction       Date:  2022-03-05       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.